Pages that link to "Q43528844"

The following pages link to Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity. (Q43528844):

Displaying 15 items.

• Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs (Q34119454) (← links)
• Cytochrome P450 polymorphisms and response to antipsychotic therapy. (Q34612118) (← links)
• Interactions between the cytochrome P450 system and the second-generation antipsychotics (Q35096587) (← links)
• Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs (Q35183961) (← links)
• Metabolic drug interactions with new psychotropic agents. (Q35619640) (← links)
• Interactions between antiepileptic and antipsychotic drugs (Q36384715) (← links)
• Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents (Q36522045) (← links)
• Metabolic drug interactions with newer antipsychotics: a comparative review. (Q36703845) (← links)
• Interactions between antiepileptics and second-generation antipsychotics. (Q37983921) (← links)
• Clinically significant drug interactions with atypical antipsychotics (Q38156416) (← links)
• Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics. (Q38734067) (← links)
• Pharmacological treatment of psychosis in epilepsy (Q44825253) (← links)
• Plasma concentrations of risperidone and olanzapine during coadministration with oxcarbazepine. (Q46460408) (← links)
• Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives. (Q52318495) (← links)
• Pharmacoepidemiology and drug safety (Q74376041) (← links)